Author

Ingela Turesson

Observed names: I Turesson, I. TURESSON, I. Turesson, I.T. Turesson, Ingelat Turesson

Observed institutions: Uppsala University, Uppsala University Hospital, The University of Texas MD Anderson Cancer Center, Sahlgrenska University Hospital, Karolinska Institutet, University Hospital of Geneva, Skåne University Hospital, University of Gothenburg, Umeå University

ORCID: 0000-0003-1536-8919

Observed ORCID: 0000-0003-1536-8919

OpenAlex ID: A5067166201

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

2004 · Ian F. Tannock, Ronald de Wit, et al. · New England Journal of Medicine · 5,740

Low-dose hypersensitivity: current status and possible mechanisms

2001 · Michael C Joiner, Brian Marples, et al. · International Journal of Radiation Oncology*Biology*Physics · 571

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials

1998 · Stefano Pasquali, J D Maqueo, et al. · Journal of Clinical Oncology · 470

Time-dose factors in radiotherapy: a review of the human data

1990 · H.D. Thames, S.M. Bentzen, et al. · Radiotherapy and Oncology · 405

Repair capacity and kinetics of human skin during fractionated radiotherapy: Erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up

1989 · Ingela Turesson, Howard D. Thames · Radiotherapy and Oncology · 335

Prognostic factors for acute and late skin reactions in radiotheraphy patients

1996 · Ingela Turesson, Jan Nyman, et al. · International Journal of Radiation Oncology*Biology*Physics · 311

A Systematic Overview of Radiation Therapy Effects in Soft Tissue Sarcomas

2003 · Hans Strander, Ingela Turesson, et al. · Acta Oncologica · 236

PDF

p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2–stimulated angiogenesis

2002 · Taro Matsumoto, Ingela Turesson, et al. · The Journal of Cell Biology · 188

Evidence for individual differences in the radiosensitivity of human skin

1992 · Susan L Tucker, Ingela Turesson, et al. · European Journal of Cancer · 186

Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity

1992 · N.G. Burnet, R. Wurm, et al. · The Lancet · 162

Optimization of uncomplicated control for head and neck tumors

1990 · Annakarin Ågren, Anders Brahme, et al. · International Journal of Radiation Oncology*Biology*Physics · 161

Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy

2002 · Akmal Safwat, Søren M Bentzen, et al. · International Journal of Radiation Oncology*Biology*Physics · 151

Individual variation and dose dependency in the progression rate of skin telangiectasia

1990 · Ingela Turesson · International Journal of Radiation Oncology*Biology*Physics · 145

The influence of fraction size in radiotherapy on the late normal tissue reaction—II: Comparison of the effects of daily and twice-a-week fractionation on human skin

1984 · Ingela Turesson, Gustaf Notter · International Journal of Radiation Oncology*Biology*Physics · 145

Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer

1995 · William A. Brock, Susan L. Tucker, et al. · International Journal of Radiation Oncology*Biology*Physics · 135

Integration of Titanium Implants in Irradiated Bone Histologic and Clinical Study

1988 · Magnus Jacobsson, Anders Tjellströum, et al. · Annals of Otology Rhinology & Laryngology · 134

Analysis of Gene Expression Using Gene Sets Discriminates Cancer Patients with and without Late Radiation Toxicity

2006 · J. Peter Svensson, Lukas J. A Stalpers, et al. · PLoS Medicine · 128

PDF

Fractionation Parameters for Human Tissues and Tumors

1989 · H.D. Thames, S.M. Bentzen, et al. · International Journal of Radiation Biology · 118

Describing patients' normal tissue reactions: Concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity

1998 · Neil G. Burnet, Jørgen Johansen, et al. · International Journal of Cancer · 113

PDF

Whole-Body Diffusion-Weighted MRI Compared With 18F-NaF PET/CT for Detection of Bone Metastases in Patients With High-Risk Prostate Carcinoma

2012 · Firas Mosavi, Silvia Johansson, et al. · American Journal of Roentgenology · 108

Specification of dose delivery in radiation therapy. Recommendation by the Nordic Association of Clinical Physics (NACP).

1997 · P Aaltonen, A Brahme, et al. · PubMed · 108

The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules

1994 · N.G Burnet, J Nyman, et al. · Radiotherapy and Oncology · 108

The influence of fraction size in radiotherapy on the late normal tissue reaction—I: Comparison of the effects of daily and once-a-week fractionation on human skin

1984 · Ingela Turesson, Gustaf Notter · International Journal of Radiation Oncology*Biology*Physics · 105

DNA double strand break quantification in skin biopsies

2004 · Olov Fredrik Qvarnström, Martin Simonsson, et al. · Radiotherapy and Oncology · 102

The progression rate of late radiation effects in normal tissue and its impact on dose-response relationships

1989 · Ingela Turesson · Radiotherapy and Oncology · 97

Works count: 147

Citation count: 12,450

H-index: 40

I10-index: 84